Epinephrine 0.3 MG auto-inject 2S
Ended Awarded Last action
- Contract number
- SPE2D326F3293
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,091
Award facts
- Contract value 100% obligated
- $2,091.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,091.00 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies on January 7, 2026, with completion scheduled for January 8, 2026. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain with extensive experience distributing branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across military healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, and includes a 30-month base period with three 30-month option periods. Through this contract vehicle, DMS Pharmaceutical Group is positioned to provide essential pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2D326F3293?
SPE2D326F3293 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on January 7, 2026.
How much is contract SPE2D326F3293 worth?
The government has obligated $2,091 on SPE2D326F3293.
Is contract SPE2D326F3293 an order under another contract?
Yes. SPE2D326F3293 is a delivery order under SPE2D021DA002, an indefinite delivery contract.
Was contract SPE2D326F3293 competed?
The extent of competition for SPE2D326F3293 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award